LUIS RUIZ: Open Payments
NPI 1265296784 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 67 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $747 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 12 | $244 |
| Otsuka America Pharmaceutical, Inc. | 14 | $182 |
| Vanda Pharmaceuticals Inc. | 11 | $180 |
| E.R. Squibb & Sons, L.L.C. | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| ABBVIE INC. | 4 | $70 |
| Lundbeck LLC | 4 | $63 |
| Alkermes, Inc. | 3 | $53 |
| Bausch Health US, LLC | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
Products named: Auvelity, REXULTI, FANAPT, COBENFY, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, APLENZIN.
Industry payments across NJ — which companies pay providers there.
